首页> 外国专利> COMPOUNDS FOR USE IN THE TREATMENT OF NEUROBLASTOMA, EWING'S SARCOMA OR RHABDOMYOSARCOMA

COMPOUNDS FOR USE IN THE TREATMENT OF NEUROBLASTOMA, EWING'S SARCOMA OR RHABDOMYOSARCOMA

机译:用于治疗神经母细胞瘤,尤文氏肉瘤或横纹肌肉瘤的化合物

摘要

The present invention relates to a method of treating cancer selected from the group consisting of neuroblastoma, Ewing's Sarcoma, or rhabdomyosarcoma comprising administering a therapeutically effective amount of a compound of formula (I), as defined herein, or a pharmaceutically acceptable salt thereof to a subject, preferably a human, in need thereof; to use of the compound of formula (I) or a pharmaceutically acceptable salt thereof for the manufacture of pharmaceutical compositions for use in the treatment of cancer selected from the group consisting of neuroblastoma, Ewing's Sarcoma, or rhabdomyosarcoma; and to use of the compound of formula (I) or a pharmaceutically acceptable salt thereof in the treatment of cancer selected from the group consisting of neuroblastoma, Ewing's Sarcoma, or rhabdomyosarcoma.
机译:本发明涉及一种治疗选自神经母细胞瘤,尤因氏肉瘤或横纹肌肉瘤的癌症的方法,该方法包括将治疗有效量的如本文所定义的式(I)化合物或其药学上可接受的盐施用于神经母细胞瘤。有需要的受试者,优选为人;式(I)化合物或其药学上可接受的盐在制备用于治疗选自神经母细胞瘤,尤因氏肉瘤或横纹肌肉瘤的癌症的药物组合物中的用途;以及式(I)化合物或其药学上可接受的盐在治疗选自神经母细胞瘤,尤文氏肉瘤或横纹肌肉瘤的癌症中的用途。

著录项

  • 公开/公告号KR20150002623A

    专利类型

  • 公开/公告日2015-01-07

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号KR20147026928

  • 发明设计人 HUANG XIZHONG;

    申请日2013-03-28

  • 分类号A61K31/427;A61K31/4439;A61K31/497;A61K31/506;A61P35;

  • 国家 KR

  • 入库时间 2022-08-21 15:00:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号